CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 195 filers reported holding CHEMOCENTRYX INC in Q4 2021. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $27,973,000 | +1204.7% | 541,480 | +525.8% | 0.06% | +2750.0% |
| Q2 2022 | $2,144,000 | +15.1% | 86,525 | +16.5% | 0.00% | +100.0% |
| Q1 2022 | $1,863,000 | -19.7% | 74,285 | +16.5% | 0.00% | -50.0% |
| Q4 2021 | $2,321,000 | +584.7% | 63,788 | +221.7% | 0.00% | – |
| Q3 2021 | $339,000 | -21.0% | 19,829 | -38.1% | 0.00% | – |
| Q2 2021 | $429,000 | -73.8% | 32,057 | +0.4% | 0.00% | -100.0% |
| Q1 2021 | $1,636,000 | -28.2% | 31,923 | -13.2% | 0.00% | 0.0% |
| Q4 2020 | $2,278,000 | -61.6% | 36,795 | -66.0% | 0.00% | -71.4% |
| Q3 2020 | $5,926,000 | +10.5% | 108,151 | +16.0% | 0.01% | +16.7% |
| Q2 2020 | $5,365,000 | +24.0% | 93,241 | -13.4% | 0.01% | 0.0% |
| Q1 2020 | $4,328,000 | +49.5% | 107,718 | +47.2% | 0.01% | +100.0% |
| Q4 2019 | $2,895,000 | – | 73,195 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 276,400 | $4,726,000 | 1.88% |
| TANG CAPITAL MANAGEMENT LLC | 500,000 | $8,550,000 | 1.78% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 94,300 | $7,131,000 | 1.72% |
| Integral Health Asset Management, LLC | 300,000 | $5,130,000 | 1.48% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 139,200 | $2,380,000 | 1.35% |
| MANGROVE PARTNERS IM, LLC | 686,300 | $11,736,000 | 1.05% |
| Ikarian Capital, LLC | 600,000 | $10,261,000 | 0.72% |
| Ikarian Capital, LLC | 600,000 | $10,260,000 | 0.72% |
| Sofinnova Investments, Inc. | 517,708 | $8,853,000 | 0.52% |
| Birchview Capital, LP | 25,000 | $428,000 | 0.29% |